Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × repotrectinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Neoplasm Metastasis 2 Thyroid Neoplasms 1 Thyroid Diseases 1 Thoracic Neoplasms 1 Solitary Fibrous Tumors 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Lung Neoplasms 1 Lung Diseases 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Head and Neck Neoplasms 1 Granuloma, Plasma Cell 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1 Digestive System Neoplasms 1

Interventions

Radiosurgery 24 Magnetic Resonance Spectroscopy 20 Temozolomide 12 pembrolizumab 10 Bevacizumab 9 Specimen Handling 8 Radiotherapy 6 Nivolumab 6 Ipilimumab 6 Magnetic Resonance Imaging 5 Cyclophosphamide 5 Capecitabine 5 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 fluoromisonidazole 2 binimetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06315010 2026-02-25

REPOSE

MedSIR

Phase 2 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡